Article
Dynamic evolution of ceftazidime-avibactam resistance from a single patient through the IncX3_NDM-5 plasmid transfer and blaKPC mutation.
International journal of antimicrobial agents - 1 Aug 2024
Tang Chengkang, Shen Siquan, Yang Weiwei, Shi Qingyu, Ding Li, Han Renru, Hu Fupin
Abstract excerpt
The rapid dissemination of carbapenem-resistant Enterobacterales (CRE) especially carbapenem-resistant Klebsiella pneumoniae (CRKP) poses a great threat to global public health. Ceftazidime-avibactam, a novel β-lactam/β-lactamase inhibitor combination, has been widely used due to its excellent antibacterial activity against KPC-producing K. pneumoniae. However, several resistance mechanisms have been reported...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
